PA-PMI
Project Management Institute (PMI) today launched Make Reality , a virtual hub designed to inspire and support changemakers as they drive transformation and create positive social impact across the world while navigating the COVID-19 pandemic. Telling the unique stories of changemakers – those at the forefront of driving change, personally and professionally – as they created impact in today’s project-centered world, the virtual hub empowers changemakers to get started on their next project or see a project through to the finish line that was left on hold.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210908005777/en/
Nearly four in five consumers (79 percent) in PMI’s Make Reality Global Survey 20201 said they consider 2021 a “do-over” year due to the COVID crisis. But 83 percent said 2020 prepared them for 2021, and an even greater number (86 percent) plan to work harder this year to bring their good ideas to life.
“The pandemic disrupted countless 2020 plans, but many leaders and innovative thinkers used the time wisely to map out their next moves,” said PMI Chief Operating Office Mike DePrisco. “As more communities and organizations across the globe cautiously turn to recovery and revival, teams are increasingly focused on turning their stalled projects into reality. However, making that idea a reality isn’t easy and requires effective project skills and new ways of working; that’s why PMI is empowering changemakers to take action through the Make Reality virtual hub.”
From KICKOFF™ to Power Skills
The PMI virtual hub features videos and true stories of changemakers across the globe turning their ideas into reality – from creating biodegradable batteries for electric vehicles in India to restoring animal habitats following the Australian wildfires. The hub also connects changemakers to PMI tools, resources, and courses on project management best practices, including KICKOFF – a free, 45-minute digital course and toolkit that guides learners through the basics of project management with bite-sized content and downloadable templates they can quickly implement on the job.
The Make Reality virtual hub also helps project management professionals and non-professionals identify their unique changemaker persona and offers information about the “power skills” or social behaviors – like communications, empathy, collaborative leadership, and an innovative mindset – that are important in driving change and allow people to work well together to get things done. They complement the technical or vocational skills required and can often spell the difference between a project’s success or failure.
Research Offers Reasons for Optimism
The vast majority of changemakers are open to learning new skills. According to the PMI survey, 81 percent of consumers plan to learn new skills to bring their projects to life. Nearly three-quarters (73 percent) plan to take a more active role in driving change, and 66 percent are optimistic about their ability to be successful.
Consumers are bringing similar ambitions – and a certain adventurous spirit – to their professional lives. Over two in ten (22 percent) are interested in starting their own business, and a similar number (22 percent) want to start a new job. They are also interested in increasing their level of responsibility on the job (28 percent) and learning new, job-related skills (31 percent).
Among these are power skills like creativity (35 percent), communication (38 percent), and collaboration/teamwork (25 percent), as well as project management skills themselves (24 percent)2 .
“We hope to build on this sense of excitement and optimism with our Make Reality virtual hub,” DePrisco said. “We believe there’s a pent-up desire to make change and to have impact in all spheres of peoples’ lives – personal, professional, and in the realm of social good. Our goal is to give people the tools – and a bit of inspiration – to get started.”
For inspiration and to take the next step into turning their idea into reality, changemakers can visit pmi.org/Make-Reality .
About Project Management Institute
Project Management Institute (PMI) is the world's leading professional association for a growing community of millions of project professionals and changemakers worldwide.
As the world’s leading authority on project management, PMI empowers people to make ideas a reality. Through global advocacy, networking, collaboration, research, and education, PMI prepares organizations and individuals to work smarter so they can drive success in a world of change.
Building on a proud legacy dating to 1969, PMI is a “for-purpose” organization working in nearly every country around the world to advance careers, strengthen organizational success, and enable changemakers with new skills and ways of working to maximize their impact. PMI offerings include globally recognized standards, certifications, online courses, thought leadership, tools, digital publications, and professional communities. Visit us at pmi.org and connect with us on LinkedIn , Facebook , Twitter , and Instagram to keep up with the latest from PMI.
Survey Methodology:
Project Management Institute fielded two online global surveys among 8750 total respondents between November 6 and November 25, 2020. A total number of 1750 business leaders who influence or make decisions on behalf of their company (250 per country) and 7000 general consumers (1000 per country) were surveyed from the following countries: United States, United Kingdom, Australia, India, Singapore, South Africa and the United Arab Emirates. Best efforts were made to balance the general consumer samples to reflect their respective national representation across gender, age, region, household income and race/ethnicity. The estimated margin of error (MOE) was 2.3% for the business thought leader survey and 1.7% for the general consumer survey at a 95% level of confidence.
_______________
1
Project Management Institute. (2020). Make Reality Global Survey.
2
Project Management Institute. (2020). Make Reality Global Survey.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210908005777/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
